top of page
NEW dr medge_logo (1).png

Groundbreaking Cancer Recovery Case Study: Biophoton Therapy
Shows Remarkable Results in Live Blood Analysis

As a holistic wellness practitioner, I'm excited to share extraordinary research that demonstrates the profound healing potential of energy-based therapies. Published in Biomedical Journal of Scientific & Technical Research, this compelling case study uses live blood microscopy to document the remarkable recovery of a lung cancer patient using biophoton therapy as supportive care.

My Perspective on This Revolutionary Evidence

What makes this research so compelling to me is that it provides visual, real-time evidence of healing at the cellular level. As someone who works with energy-based healing modalities, I've always understood that true healing begins in our cells and radiates outward. This study offers unprecedented documentation of that process over 24 days of treatment.

​

The fact that we can literally see blood transforming from a diseased state to optimal health speaks to the profound healing potential that exists within each of us when we provide the right therapeutic environment.

The Study: A 72-Year-Old Lung Cancer Survivor's Journey

This case study followed a 72-year-old male diagnosed with low-differentiation squamous cell carcinoma of the lung who had completed standard chemotherapy. Using live blood analysis under dark-field microscopy, researchers documented dramatic changes in blood morphology over 24 days of nightly biophoton therapy exposure.

Baseline: The Challenge of Post-Chemotherapy Blood

At the beginning of the study (March 25, 2025), the patient's blood showed severe post-chemotherapy complications:

​

Pathological Findings:

  • RBC rouleaux formation and clustering indicating increased blood viscosity

  • WBCs aggregated with low motility suggesting immunosuppression

  • Platelet aggregates and deformed RBCs implying oxidative stress and liver dysfunction

  • Poor microcirculation and decreased lymphocytes

​

Clinical Symptoms:

  • Liver detox dysfunction and skin conditions

  • Swallowing discomfort and sleep apnea

  • Fatigue and low pulmonary capacity

  • Poor immune activation

​

As the researchers noted: "This stage indicates active systemic inflammation, hepatic burden, and impaired microcirculation following chemotherapy."

Day 2: Early Signs of Recovery

Just two days into therapy (March 27-29, 2025), positive changes were already visible:


Microscopic Improvements:

 

  • WBCs becoming more active though still granular

  • Early terrain clearing with plasma debris present

  • Beginning of immunological rebound


Clinical Improvements:

 

  • "Inflammation has begun to subside"

  • "Overall body energy was improving"

  • "Sleep and respiration are improving, mental energy rising"

Day 11: Accelerating Detoxification

By April 5, 2025, remarkable transformation was evident:


Blood Changes:

  • RBCs showing better separation and less stacking

  • Crystal-like or necrotic cell debris observed indicating active detox

  • Large mononuclear cells suggesting immune modulation

  • Increased lymphocytes


Clinical Progress:

  • "Increased overall body function"

  • "Sleep improved further, appetite improving"

​

The researchers interpreted this as: "Evidence of tissue detoxification and immune tissue repair, likely part of regenerative phase."

Day 17: Metabolic Balance Returning

April 11, 2025 showed continued improvement:


Microscopic Observations:

  • RBCs well-spaced with improved morphology

  • Plasma is clearer

  • Detox of lipid and cholesterol crystals observed

  • Glycogen regulation and microcirculation improving


Clinical Transformation:

  • "Body energy level increased further"

  • "Eating, sleeping, and other daily activities became almost normal"

  • "Could actively participate in the normal daily activities"

Day 24: Complete Recovery

The final assessment on April 18, 2025 revealed extraordinary results:


Blood Perfection:

  • Excellent RBC morphology, vibrant and separated

  • Sparse but non-degraded WBCs

  • Clear plasma terrain

  • 4% increase in lymphocytes

​

Clinical Excellence:

  • "Improved microcirculation, better sleep and breathing, regular bowel movements"

  • "Participated in normal daily activities with a normal energy level"

​

Clinical Excellence:

"Improved microcirculation, better sleep and breathing, regular bowel movements"
"Participated in normal daily activities with a normal energy level"

Remarkable Clinical Laboratory Results

The study documented objective improvements in cancer biomarkers:


Cancer Marker Improvements:

  • 33.5% reduction in squamous cell carcinoma antigen

  • Significant drop in carcinoembryonic antigens (CEA)

​

As the researchers concluded: "This indicated that biophoton therapy can reduce the presence of cancer biomarkers in the blood circulation."

Broader Clinical Evidence

The study also referenced broader clinical experience with 44 cancer patients, showing biophoton therapy benefits included:

​

  1. Enhanced tolerance to conventional treatments for breast, kidney, gastrointestinal, prostate, and esophageal cancers

  2. Reduction in side effects including pancytopenia, neuropathy, fatigue, and anemia

  3. Improved immune function with stable blood counts during treatment

  4. Accelerated recovery with three out of four patients becoming cancer-free

  5. Quality of life improvements including better sleep and emotional well-being

  6. No reported side effects among all 44 cancer patients

The Science Behind the Healing

According to the research, biophoton therapy works through multiple mechanisms:

​

  • Enhanced microcirculation and decreased inflammation

  • Reversal of oxidative stress and cellular detoxification

  • Mitochondrial activation and improved cellular metabolism

  • Stem cell activation and immune signaling enhancement

Comparison to Standard Supportive Care

The study included a comparison showing biophoton therapy advantages:

​

  • Non-invasive and non-pharmacologic vs. drug-based interventions

  • Multi-targeted systemic effects vs. symptom-specific treatments

  • No adverse effects vs. potential toxicities

  • Home-based convenience vs. clinical administration requirements

Hope for Cancer Recovery

The researchers concluded: "This case demonstrates that biophoton co-therapy may serve as a powerful adjunctive modality to enhance treatment tolerance, mitigate side effects, and restore systemic balance in cancer patients. The observed improvements support further clinical studies to evaluate the integration of biophoton therapy into comprehensive oncology care."

​

This case study offers genuine hope for anyone dealing with cancer, demonstrating that supportive energy-based therapies can play a crucial role in recovery and healing.

​

Read the complete study: Strong Biophoton Field Therapy as a Quantum Adjunct to Enhance Cancer Recovery

​

Interested in exploring how holistic approaches might support your healing journey? Contact us to learn more about integrative therapies that honor your body's natural wisdom.

bottom of page